Grifols, S.A. (GIKLY)
OTCMKTS · Delayed Price · Currency is USD
7.49
+0.45 (6.32%)
Jul 31, 2025, 12:47 PM EDT
Grifols Employees
Grifols had 23,833 employees as of December 31, 2024. The number of employees increased by 89 or 0.37% compared to the previous year.
Employees
23,833
Change (1Y)
89
Growth (1Y)
0.37%
Revenue / Employee
$366,896
Profits / Employee
$14,657
Market Cap
9.16B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 23,833 | 89 | 0.37% |
| Dec 31, 2023 | 23,744 | -2,582 | -9.81% |
| Jan 1, 2023 | 26,326 | 3,081 | 13.25% |
| Dec 31, 2021 | 23,245 | -423 | -1.79% |
| Dec 31, 2020 | 23,668 | -335 | -1.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Grifols News
- 15 days ago - Grifols: Reassuring Evidence, Still On The Sidelines - Seeking Alpha
- 7 weeks ago - XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology - GlobeNewsWire
- 2 months ago - Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting - Business Wire
- 2 months ago - Grifols lawsuit against Gotham City to proceed after New York court ruling - Seeking Alpha
- 2 months ago - US court finds enough evidence to proceed with Grifols lawsuit against Gotham City - Reuters
- 2 months ago - Grifols: If This Works Out, It Has Massive Upside - Seeking Alpha
- 2 months ago - Grifols S.A. reports Q1 results - Seeking Alpha
- 2 months ago - Grifols, S.A. (GRFS) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha